← feed

Is NCT03063580 results overdue?

Yes — results are overdue. Primary completion was 2017-05-12; the FDAAA-801 reporting deadline (2018-05-12) passed 2962 days ago and no results are posted on ClinicalTrials.gov.

Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

NCT IDNCT03063580 ↗
SponsorSanofi (INDUSTRY)
Public issuerSanofi — SNY (CIK 0001121404) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2017-05-12 (ACTUAL)
Reporting deadline2018-05-12 (completion + 365d)
Days overdue2962
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 f8cfbca7c3b28d20… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03063580. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →